SUZANNE KELLER: Open Payments
NPI 1093151565 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $248 · 2025 $661
Food & beverage: $448Education: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $331 |
| Vanda Pharmaceuticals Inc. | 4 | $108 |
| Lundbeck LLC | 2 | $46 |
| Alkermes, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: AUSTEDO XR, FANAPT, REXULTI, ARISTADA, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, SUBLOCADE.
Industry payments across CA — which companies pay providers there.
